Group One Trading’s Aptose Biosciences, Inc. APTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3
| Closed | -$9 | – | 8859 |
|
|
2025
Q1 | $9 | Sell |
3
-1
| -25% | -$5 | ﹤0.01% | 7455 |
|
|
2024
Q4 | $26 | Hold |
4
| – | – | ﹤0.01% | 7137 |
|
|
2024
Q3 | $47 | Hold |
4
| – | – | ﹤0.01% | 6499 |
|
|
2024
Q2 | $87 | Hold |
4
| – | – | ﹤0.01% | 6559 |
|
|
2024
Q1 | $191 | Hold |
4
| – | – | ﹤0.01% | 6812 |
|
|
2023
Q4 | $289 | Hold |
4
| – | – | ﹤0.01% | 7136 |
|
|
2023
Q3 | $322 | Hold |
4
| – | – | ﹤0.01% | 7396 |
|
|
2023
Q2 | $534 | Sell |
4
-5
| -56% | -$1.03K | ﹤0.01% | 7358 |
|
|
2023
Q1 | $2.46K | Sell |
9
-70
| -89% | -$20.3K | ﹤0.01% | 6561 |
|
|
2022
Q4 | $20.6K | Sell |
79
-62
| -44% | -$16.7K | ﹤0.01% | 5583 |
|
|
2022
Q3 | $38K | Sell |
141
-32
| -18% | -$11K | ﹤0.01% | 5626 |
|
|
2022
Q2 | $58K | Sell |
173
-72
| -29% | -$34.4K | ﹤0.01% | 5443 |
|
|
2022
Q1 | $150K | Sell |
245
-86
| -26% | -$47.6K | ﹤0.01% | 5096 |
|
|
2021
Q4 | $201K | Buy |
331
+116
| +54% | +$109K | ﹤0.01% | 5081 |
|
|
2021
Q3 | $211K | Sell |
215
-125
| -37% | -$156K | ﹤0.01% | 5119 |
|
|
2021
Q2 | $508K | Buy |
+340
| New | +$741K | ﹤0.01% | 4208 |
|
|
2020
Q4 | – | Sell |
-40
| Closed | -$94K | – | 7179 |
|
|
2020
Q3 | $108K | Buy |
+40
| New | +$99.7K | ﹤0.01% | 4144 |
|
|
2020
Q2 | – | Sell |
-5
| Closed | -$16.1K | – | 6338 |
|
|
2020
Q1 | $14K | Buy |
+5
| New | +$14.9K | ﹤0.01% | 4434 |
|
|
2019
Q4 | – | Sell |
-1
| Closed | -$1.3K | – | 5784 |
|
|
2019
Q3 | $1K | Buy |
+1
| New | +$1.14K | ﹤0.01% | 5033 |
|
Other funds holding APTO
DS
GG
TWC
CSC
Group One Trading's APTO Position: Q2 2025 in Review
Group One Trading sold out of Aptose Biosciences, Inc. (APTO) in Q2 2025, closing a stake of 3 shares — an estimated $9 sold.
Group One Trading first reported a position in APTO in Q3 2019 and held it in 19 quarters. The position peaked at $508K in Q2 2021. 4 funds tracked by Wall St. Rank hold APTO as of Q2 2025.
- Group One Trading reported no remaining Aptose Biosciences, Inc. position as of Q2 2025 after selling out during the quarter.
- Group One Trading sold 3 Aptose Biosciences, Inc. shares in Q2 2025, an estimated $9.
- Group One Trading first reported a position in Aptose Biosciences, Inc. in Q3 2019 and held it in 19 quarters.
- Group One Trading's Aptose Biosciences, Inc. position peaked at $508K in Q2 2021.
- 4 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2025.
Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.